Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves the subsequent pregnancy rate

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Bartáková, Jana ^a   Potluková, Eliška ^a   Rogalewicz, Vladimír ^b   Fait, Tomáš ^a   Schöndorfová, Dita ^a   Telička, Zdeněk ^a   Krátký, Jan ^a   Jiskra, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC PROCEDURE; FEMALE; FEMALE INFERTILITY; FOLLOW UP; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SCREENING; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN BLOOD LEVEL;

ABORTION, SPONTANEOUS; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; INFERTILITY, FEMALE; IODIDE PEROXIDASE; MASS SCREENING; PREGNANCY; PREGNANCY RATE; THYROTROPIN; THYROXINE;

EID: 84887957009     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-217     Document Type: Article

References (37)

1. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997, 18(3):404-433. 10.1210/er.18.3.404, 9183570.
2. Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol 2000, 53(3):265-278.
3. Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009, 160(5):791-797. 10.1530/EJE-08-0890, 19228824.
4. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, Faix JD, Klein RZ. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000, 7(3):127-130. 10.1136/jms.7.3.127, 11126160.
5. Potlukova E, Potluka O, Jiskra J, Limanova Z, Telicka Z, Bartakova J, Springer D. Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women. J Clin Endocrinol Metab 2012, 97(6):1945-1952. 10.1210/jc.2011-3275, 22438224.
6. de Escobar GM, Obregon MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004, 18(2):225-248. 10.1016/j.beem.2004.03.012, 15157838.
7. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999, 341(8):549-555. 10.1056/NEJM199908193410801, 10451459.
8. Monteleone P, Parrini D, Faviana P, Carletti E, Casarosa E, Uccelli A, Cela V, Genazzani AR, Artini PG. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol 2011, 66(2):108-114. 10.1111/j.1600-0897.2010.00961.x, 21241400.
9. Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G. Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000, 14(4):270-274. 10.3109/09513590009167693, 11075298.
10. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997, 90(3):364-369. 10.1016/S0029-7844(97)00283-4, 9277645.
11. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990, 264(11):1422-1425. 10.1001/jama.1990.03450110068029, 2118190.
12. Mannisto T, Vaarasmaki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, Bloigu A, Jarvelin MR, Suvanto-Luukkonen E. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009, 94(3):772-779.
13. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006, 91(7):2587-2591. 10.1210/jc.2005-1603, 16621910.
14. Vaquero E, Lazzarin N, De Carolis C, Valensise H, Moretti C, Ramanini C. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 2000, 43(4):204-208. 10.1111/j.8755-8920.2000.430404.x, 10836249.
15. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21(10):1081-1125. 10.1089/thy.2011.0087, 3472679, 21787128.
16. Branch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage. N Engl J Med 2010, 363(18):1740-1747. 10.1056/NEJMcp1005330, 20979474.
17. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 2012, 97(5):1536-1546. 10.1210/jc.2011-2884, 22399510.
18. Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 2008, 158(6):841-851. 10.1530/EJE-07-0882, 18505905.
19. Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009, 200(3):267 e261-267.
20. Zamrazil V, Bilek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid 2004, 14(1):49-56. 10.1089/105072504322783849, 15009914.
21. Jiskra J, Bartakova J, Holinka S, Limanova Z, Springer D, Fait T, Antosova M, Telicka Z, Potlukova E. Low concordance between positive antibodies to thyroperoxidase and thyroid ultrasound autoimmune pattern in pregnant women. Endocr J 2011, 58(10):849-859. 10.1507/endocrj.EJ11-0026, 21873803.
22. Chatfield C. Statistics for technology: a course in applied statistics, 3rd edn. London 1983, New York: Chapman and Hall.
23. Department of financial policy: Fiscal outlook of the Czech Republic 2011, 31. Prague: The Ministry of Finance of the Czech Republic.
24. Brent RJ. Cost-benefit analysis and health care evaluations. Cheltenham, UK 2003, Northhampton, MA: Edward Elgar.
25. Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2011, 95(5):1650-1654. 10.1016/j.fertnstert.2010.12.004, 21193190.
26. Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q, Li J, Shen XT, Li J. Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci 2012, 9(2):121-125. 10.7150/ijms.3467, 3258552, 22253557.
27. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, Locorotondo G, Caroli P, Pezzarossa A, Dazzi D, et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005, 20(6):1529-1533. 10.1093/humrep/deh843, 15878930.
28. Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 2008, 14(4):458-464. 10.4158/EP.14.4.458, 18558600.
29. Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999, 71(5):843-848. 10.1016/S0015-0282(99)00091-6, 10231043.
30. Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N. The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 1993, 60(6):1001-1005.
31. Abbassi-Ghanavati M. Thyroid autoantibodies and pregnancy outcomes. Clin Obstet Gynecol 2011, 54(3):499-505. 10.1097/GRF.0b013e31822730b9, 21857181.
32. Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 1998, 179(6 Pt 1):1583-1586.
33. Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 2008, 4(7):394-405. 10.1038/ncpendmet0846, 18506157.
34. Hetzel BS, Pandav CS. S.O.S for a Billion: The Conquest of Iodine Deficiency Disorders 1994, Delhi: Oxford: Oxford University Press.
35. Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet 2008, 372(9645):1251-1262. 10.1016/S0140-6736(08)61005-3, 18676011.
36. Petrou S. The economic consequences of preterm birth during the first 10 years of life. BJOG 2005, 112(Suppl 1):10-15.
37. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008, 371(9608):261-269. 10.1016/S0140-6736(08)60136-1, 18207020.